These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6133288)

  • 1. Effects of three narcotic antagonists (naltrexone, diprenorphine, and S-20682) on blood pressure, heart rate and electrical cortical activity.
    Freye E; Hartung E; Schenk GK
    Pharmacology; 1983; 26(2):110-6. PubMed ID: 6133288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of late fentanyl-induced respiratory depression after the injection of opiate antagonists naltrexone and S-20682: comparison with naloxone.
    Freye E; Hartung E; Kaliebe S
    Br J Anaesth; 1983 Jan; 55(1):71-7. PubMed ID: 6129881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog.
    Freye E; Schmidhammer H; Latasch L
    Anesth Analg; 2000 Jun; 90(6):1359-64. PubMed ID: 10825321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects.
    Freye E; Latasch L; Portoghese PS
    Eur J Anaesthesiol; 1992 Nov; 9(6):457-62. PubMed ID: 1330549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine.
    Latasch L; Freye E
    Acta Anaesthesiol Belg; 1993; 44(3):93-102. PubMed ID: 8310788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bremazocine: an opiate that induces sedation and analgesia without respiratory depression.
    Freye E; Hartung E; Schenk GK
    Anesth Analg; 1983 May; 62(5):483-8. PubMed ID: 6301311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
    Pircio AW; Gylys JA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of an etorphine-acepromazine preparation: experiments in dogs and horses.
    Schlarmann B; Görlitz BD; Wintzer HJ; Frey HH
    Am J Vet Res; 1973 Mar; 34(3):411-5. PubMed ID: 4691487
    [No Abstract]   [Full Text] [Related]  

  • 10. [Precipitation and prevention of abstinence in acutely morphinized rats and mice: comparisons between naloxone, naltrexone, and diprenorphine (author's transl)].
    Tremblay E; Colombel MC; Jacob J
    Psychopharmacology (Berl); 1976 Aug; 49(1):41-8. PubMed ID: 822446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local opiate receptors in the sinoatrial node moderate vagal bradycardia.
    Farias M; Jackson K; Stanfill A; Caffrey JL
    Auton Neurosci; 2001 Feb; 87(1):9-15. PubMed ID: 11270142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular effects of a chimeric opioid peptide based on morphiceptin and PFRTic-NH2.
    Li M; Zhou L; Ma G; Cao S; Dong S
    Peptides; 2013 Jan; 39():89-94. PubMed ID: 23159788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary effects of carfentanil in dama gazelles (Gazella dama).
    Schumacher J; Heard DJ; Young L; Citino SB
    J Zoo Wildl Med; 1997 Jun; 28(2):166-70. PubMed ID: 9279405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central hypotensive effect of diprenorphine in normotensive rat and SHR.
    Bellet M; Elghozi JL; Meyer P
    Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):147-51. PubMed ID: 7305547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of 20681-S and 20682-S, 6-oxo-N-cyclopropylmethylmorphinans, as narcotic antagonist analgesics.
    Hirose K; Matsushita A; Kojima Y; Eigyo M; Jyoyama H; Shiomi T; Tsukinoki Y; Hatakeyama H; Matsubara K; Kawasaki K
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):79-91. PubMed ID: 43119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of (minus)-3-hydroxy-N-cyclopropylmethylmorphinan (cyclorphan).
    Harris LS; Pierson AK; Dembinski JR; Dewey WL
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):112-26. PubMed ID: 4382141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.